With MPs discussing the condition in Parliament this week, COVER investigates what advisers should be aware of when discussing diabetes with clients
While the idea of a diabetes debate in Parliament this week may seem a tad pointless with Brexit discussions still up in the air, it is not an issue we can afford to ignore - both in society and as an industry. Questions might remain around supplies of insulin in the UK post-EU, but another is the extent to which the protection and health industry can extend itself to provide better access to insurance to people suffering from type 1 and type 2 diabetes. Access Life cover is currently available on the market through insurers such as Royal London and The Exeter, with its ‘managed li...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.